1. Yang JL, Qu XJ, Russell PJ, Goldstein D: Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon-alpha. Gut 2004,53(1): 123-9.
2. Qu XJ, Yang JL, Russell PJ, Goldstein D: Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment. The Journal of Urology, 2004, 172: 733-738.
3. Yang JL, Qu XJ, Russell PJ, Goldstein D: Interferon-alpha promotes the anti-proliferative effect of Erlotinib(OSI-774) on human colon cancer cell lines. Cancer Letter 2005 225:61-74.
4. Yang JL, Qu XJ, Russell PJ, Goldstein D: Interferon-alpha promote the anti-proliferative effects of Gefitinib (ZD1839) on human colon cancer cell lines. Oncology 2005. 69: 224-238.
5. SHU-XIANG CUI, XIAN-JUN QU, YAN-YING XIE, LING ZHOU, MUNEHIRO NAKATA, MASATOSHI MAKUUCHI3, WEI TANG. Curcumin inhibits telomerase activity in human cancer cell lines. Inter Molecular Med 18, 227-231, 2006.
6. XIAN-JUN QU, YUN-XIA YUAN, ZHI-GANG TIAN, WEN-FANG XU, MING-HUI CHEN, SHU-XIANG CUI, QIAN GUO, RUOYAN GAI, MASATOSHI MAKUUCHI, MUNEHIRO NAKATA and WEI TANG. Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2 for suppressing tumor invasion and metastasis, J Inter Molecular Med. 2006, 18(4): 609-14.
7. XIANJUN QU, YUNXIA YUAN, WENFANG XU, MINGHUI CHEN, SHUXIANG CUI, HONG MENG, MASATOSHI MAKUUCHI, MUNEHIRO NAKATA and WEI TANG. Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppressing matrix metalloproteinase activity, Anticancer Res, 26: 5A, 3573-3578, 2006.
8. Jian Liu, Wen-fang Xu, Shu-xiang Cui, Yong Zhou, Yun-xia Yuan, Ming-hui Chen, Qian Guo, Ruoyan Gai, Masatoshi Makuuchi, Wei Tang, Xian-jun Qu*:The inhibition of human gastric carcinoma cell growth by the atofluding derivative N3-o-toluyl-fluorouracil. World Journal of Gastroenterology. 12: 6766-6770, 2006.
9. Jia-Lin Yang, Xian-Jun Qu, Vanessa M. Hayes, Phillip C. Brenner, Pamela J. Russell, David Goldstein: Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha. BJU Int. 2007, 99:1539-45.
10. Xian-jun QU, Shu-xiang CUI, Zhigang TIAN, Xun LI, Ming-hui CHEN, Wen-fang XU, Yoshinori Inagaki, Ying-bing Deng, Masatoshi Makuuchi, Munehiro NAKATA and Wei TANG: Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10. Anticancer Res, 2007, 27: 2427-2432.
11. Jian Liu, Xun Li, Yan-na Cheng, Shu-xiang Cui, Ming-hui Chen, Wen-fang Xu, Zhi-gang Tian, Masatoshi Makuuchi, Wei Tang a,d, Xian-jun Qu*:Inhibition of human gastric carcinoma cell growth by treatment of N3-o-toluyl-fluorouracil as a precursor of 5-fluorouracil Eur J Pharmacol. 2007; 574:1-7.
12. Shi YO, Qu XJ, Liao YX, Xie CF, Cheng YN, Li S, Lou HX. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Eur J Pharmacol. 2008;584:66-71.
13. Shi YO, Qu XJ, Yuan HQ, Li S, Qu JB, Lou HX. Marchantin C, a macrocyclic bisbibenzyl, induces apoptosis of human glioma A172 cells. Cancer Lett. 2008;262:173-82.
14. Subo Wang, Yanna Cheng, Fengshan Wang, Lirui Sun, Chunhui Liu,
Guanjun Chen, Yuhua Li, S.G. Ward, Xian-jun Qu*:Inhibition activity of sulfated polysaccharide of Sepiella maindroni ink on matrix metalloproteinase (MMP)-2 Biomedicine & Pharmacotherapy, 2008, 62: 297-302.
15. Yang JL, Qu XJ, Yu Y, Kohn EC, Friedlander ML. Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency. Int. J. Cancer 2008;123:258-263.
16. Fu-Jun Gao, Shu-Xiang Cui, Ming-Hui Chen, Yan-Na Cheng, Li-Rui Sun, S. G Ward, Wei Tang, Xian-jun Qu*. Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sciences 2008, 83; 815-820.
17. Ming-hui Chen, Shu-xiang Cui, Yan-na Cheng, Li-rui Sun, Qian-bin Li, Wen-fang Xu, S.G Ward, Wei Tang, Xian-jun Qu*. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion via suppressing matrix metalloproteinase activity. Anti-cancer drugs, 2008, 19:957-965.
18. Li-rui Sun, Shu-xiang Cui and Xian-jun Qu*. OVERCOMING MULTIDRUG RESISTANCE IN CANCER: AN UPDATE ON RESEARCH OF NATURAL PRODUCTS. Drugs of the Future 2009, 34(1): 53-59.
19. Wang SB, Cheng YN, Cui SX, Zhong JL, Ward SG, Sun LR, Chen MH, Kokudo N, Tang W, Xian-jun Qu*. Des-gamma-carboxy prothrombin stimulates human vascular endothelial cell growth and migration. Clin Exp Metastasis. 2009, 26(5):469-77.
20. Shi YQ, Qu XJ, Sun B, Cheng YN, Li S, Li X, Lou HX. Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro. Cancer Lett. 2009;276(2):160-70.
21. Meng Ma, Xian-jun Qu*, Guo-Ying Mu, Ming-Hui Chen, Yan-Na Cheng, Norihiro Kokudo, Wei Tang, Shu- Xiang Cui. Vitamin K2 Inhibits the Growth of Hepatocellular Carcinoma via Decrease of Des-gamma-carboxy Prothrombin. Chemotherapy, 2009; 55:28-35.
22. Li-rui Sun, Xun Li, Yan-na Cheng, Hong-yu Yuan, Ming-hui Chen, Wei Tang, Stephen Geoffrey Ward, Xian-jun Qu*. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells Biomedicine & Pharmacotherapy 2009; 63: 202-208.
23. Xian-Jun Qu, Xue Xia, Yuan-Shu Wang, Mei-Juan Song, Li-Li Liu, Yan-Ying Xie, Yan-Na Cheng, Xiang-Juan Liu, Lu-Lu Qiu, Lan Xiang, Jian-Jun Gao, Xiao-Fan Zhang, Shu-Xiang Cui. Protective effects of salvia plebeia compound homoplantaginin on hepatocyte injury. Food Chem Toxicol 2009, 47:1710-1715.
24. Zhang X, Zhong JL, Liu W, Gao Z, Xue X, Yue P, Wang L, Zhao C, Xu W, Qu X. N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU. Cancer Chemother Pharmacol. 2009 Sep 16. [Epub ahead of print]